Spectrum Pharmaceuticals

.

FDA OK’s Spectrum Cancer Drug for Wider Use

Spectrum Pharmaceuticals

An Irvine drug maker, Spectrum Pharmaceuticals Inc., has said that it got regulatory approval for an expanded use of a cancer drug.

Spectrum said that the FDA approved Zevalin as an early treatment for a blood cancer, in patients with non-Hodgkin's lymphoma. The drug was used previously on patients whose tumors did not respond to other treatments.

Spectrum Pharmaceuticals inks 50:50 JV pact with Cell Therapeutics

Spectrum Pharmaceuticals inks 50:50 JV pact with Cell Therapeutics Spectrum Pharmaceuticals and Cell Therapeutics have entered into an agreement to form a 50:50 owned joint venture, RIT Oncology, to commercialize and develop Zevalin in the United States.

Latest News

Wal-Mart’s New Fix-it Man Has Never Worked in U.S Before
Obama Steps Up Drive to Stop Tax Loopholes for  “Corporate Deserters”
Widening Quarterly Losses Pull Down Amazon Shares
New Zealand Once Again Raises Its Interest Rate Now to 3.5 Percent
UN Human Development Report Points at Inequality for Slow Progress
Facebook Perched to Reach a Record High After Heavy Quarterly Gains
July HSBC Survey Reveal China PMI at All Time High in 18-months
A Woman for the First Time to Join Board of American Apparel
Glaciers Melt near Lahaul, Spiti Make Officials Warn about Flooding
A.H. Belo Corp. Will Sell Providence Journal Newspaper to New Media
Comcast’s Second Quarter Earnings Increase as a Result of Added Internet Custome
Sugar tax Make it to San Francisco Ballot in a 6-4 Vote
Syndicate content